Skip to main content

Advertisement

Log in

Improvement of rifamycin B production using mutant strains of Amycolatopsis mediterranei

  • Published:
Bioprocess Engineering Aims and scope Submit manuscript

Abstract

Two mutant strains of Amycolatopsis mediterranei VA17 and VA18 were isolated using physical (UV) and chemical (NTG) mutagens gave high rifamycin B than the parent type when grown in the same fermentation medium with a pH of 7.2, temperature 32 °C for a period of 12 days. The cultural conditions of both mutant strains are similar to the parent strain except temperature which was higher by 4 °C. By this mutation and selection study, rifamycin B production was improved from 1400 mg/l to 2450 mg/l.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 12 April 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Venkateswarlu, G., Murali, P., Sharma, G. et al. Improvement of rifamycin B production using mutant strains of Amycolatopsis mediterranei . Bioprocess Engineering 23, 315–318 (2000). https://doi.org/10.1007/s004499900068

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004499900068

Keywords

Navigation